Cargando…

Efficiency of Nebulizing Furosemide in the Treatment of Chronic Pulmonary Obstructive Disease: A Systematic Review and Meta-Analysis of Clinical Trials

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in humans. Among both oral and intravenous diuretics, nebulizing furosemide (Lasix) is the most commonly used agent. The purpose of this study was to ascertain the therapeutic effects of nebulizing f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghaysouri, Abas, Basati, Gholam, Shams, Morteza, Tavan, Hamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Research Institute of Tuberculosis and Lung Disease 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088148/ https://www.ncbi.nlm.nih.gov/pubmed/33959171

Ejemplares similares

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease
por: Leaker, Brian R, et al.
Publicado: (2015)

Sudden cardiac death in COVID-19 patients, a report of three cases
por: Shirazi, Samira, et al.
Publicado: (2020)

Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
por: Mohtadi, Negar, et al.
Publicado: (2020)

Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease
por: Santus, Pierachille, et al.
Publicado: (2017)

Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Rui, et al.
Publicado: (2020)

The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
por: Talwar, Deepak, et al.
Publicado: (2021)

New clinical experiences and evaluation of clinical and paraclinical features of deceased patients with COVID-19 infection referred to Shahid Mostafa Khomeini Hospital of Ilam
por: Ghaysouri, Abas, et al.
Publicado: (2020)

Combination adjunctive nebulized furosemide and salbutamol versus single agent therapy in COPD patients: A randomized controlled trial
por: Saba, Mohammadali, et al.
Publicado: (2020)

Clinical evaluation of nebulized verapamil in out‐patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease
por: Fahimi, Fanak, et al.
Publicado: (2022)

In Silico Characterization of an Important Metacyclogenesis Marker in Leishmania donovani, HASPB1, as a Potential Vaccine Candidate
por: Kordi, Bahareh, et al.
Publicado: (2023)

The Efficacy of Nebulized Furosemide and Salbutamol Compared with Salbutamol Alone in Reactive Airway Disease: A Double Blind Randomized, Clinical Trial
por: Masoumi, Kambiz, et al.
Publicado: (2014)

Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department
por: Gueho, Florian, et al.
Publicado: (2016)

Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis
por: Lee, Tao Han, et al.
Publicado: (2021)

Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β(2)-Agonists
por: Bollu, Vamsi, et al.
Publicado: (2016)

Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
por: Hildreth, Leah, et al.
Publicado: (2020)

Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial
por: Janowiak, Piotr, et al.
Publicado: (2017)

Effect of Inhaled Nebulized Furosemide (40 and 120 mg) on Breathlessness during Exercise in the Presence of External Thoracic Restriction in Healthy Men
por: Waskiw-Ford, Marcus, et al.
Publicado: (2018)

Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease(*)
por: Samsamshariat, Saedziaaldin, et al.
Publicado: (2011)

Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease
por: Soltaninejad, Forogh, et al.
Publicado: (2016)

Effect of Nebulized Verapamil on Oxygenation in Chronic Obstructive Pulmonary Disease (COPD) Patients Admitted to the Intensive Care Unit
por: Pourdowlat, Guitti, et al.
Publicado: (2019)

Nebulised furosemide for the treatment of patients with obstructive lung disease: a systematic review protocol
por: Veldhoen, Richard, et al.
Publicado: (2023)

Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients
por: Basati, Gholam, et al.
Publicado: (2011)

Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2018)

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment
por: Celli, Bartolome R, et al.
Publicado: (2019)

Evaluation of the therapeutic effect of the plasma of recovered COVID-19 patients for treating the patients admitted to the intensive care unit
por: Ghaysouri, A., et al.
Publicado: (2021)

Systematic review on telemedicine platforms in lockdown periods: Lessons learned from the COVID-19 pandemic
por: Shanbehzadeh, Mostafa, et al.
Publicado: (2021)

Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease
por: Pleasants, Roy A.
Publicado: (2018)

Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease
por: Hvisdas, Christopher
Publicado: (2021)

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022)

Return to Work in Cancer Patients: A Systematic Review and Meta-analysis
por: Tavan, Hamed, et al.
Publicado: (2019)

Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials
por: Hu, Han-Shuo, et al.
Publicado: (2022)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Heliox-Driven Nebulization Has a Positive Effect on the Lung Function in Lipopolysaccharide-Induced Chronic Obstructive Pulmonary Disease Rat Model
por: Wu, Wenwen, et al.
Publicado: (2016)

Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis
por: Zheng, Jin-Ping, et al.
Publicado: (2019)

Future Trends in Nebulized Therapies for Pulmonary Disease
por: McCarthy, Sean D., et al.
Publicado: (2020)

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials
por: Sethi, Sanjay, et al.
Publicado: (2020)

In vitro delivery efficiencies of nebulizers for different breathing patterns
por: Park, Hyun Mok, et al.
Publicado: (2021)

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease
por: Pudi, Krishna K., et al.
Publicado: (2017)

Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China
por: Zhang, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v67gv78r036q8pnj7874otdu1f